Abstract
The Human Genome Project revolutionized biomedical research. Could mapping the immune system be the next frontier for human health? We caught up with the founder and CEO of the Human Vaccines Project, Wayne Koff, to find out how the initiative aims to decode the immune system and speed up vaccine development.Charlotte Barker, Editor, Vaccine Insights speaks to Wayne Koff, Human Vaccines Project & Harvard TH Chan School of Public HealthWayne Koff, PhD, is the founding president and CEO of the Human Vaccines Project and adjunct professor of epidemiology at the Harvard T.H. Chan School of Public Health. Prior to joining the Human Vaccines Project, Koff was chief scientific officer and senior vice president of research and development at the International AIDS Vaccine Initiative (IAVI) in New York City for 17 years. Earlier in his career, Koff held leadership roles including vice president of vaccine research and development at United Biomedical Inc. (UBI) and chief of the Vaccine Research and Development Branch, Division of AIDS, at the National Institute of Allergy and Infectious Diseases. An internationally recognized viral immunologist in the field of AIDS vaccine research and development, he has been twice honored by the US Department of Health and Human Services with the Special Act of Service Award for developing innovative strategies for accelerating global efforts in AIDS vaccine development.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
